2-(tert-Butyl)-4-chloro-6-(trifluoromethyl)pyrimidine

Catalog No. :
ACDCTS517
CAS No. :
193611-28-8
Molecular Formula :
C9H10ClF3N2
Molecular Weight :
238.64

IUPAC Name:2-(tert-butyl)-4-chloro-6-(trifluoromethyl)pyrimidine

2-(tert-Butyl)-4-chloro-6-(trifluoromethyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$320.00Login to see priceInquiryInquiry
1g95%$799.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(tert-Butyl)-4-chloro-6-(trifluoromethyl)pyrimidine
IUPAC Name2-(tert-butyl)-4-chloro-6-(trifluoromethyl)pyrimidine
MDL No.MFCD18254267
Molecular FormulaC9H10ClF3N2
Molecular Weight238.64
SMILESFC(C1=CC(Cl)=NC(C(C)(C)C)=N1)(F)F
InChI KeyPRGHYYFMWHWPRH-UHFFFAOYSA-N
Synonym2-tert-Butyl-4-chloro-6-trifluoroMethyl-pyriMidine;2-t-butyl-4-chloro-6-trifluoromethylpyrimidine;4-Chloro-2-(1,1-dimethylethyl)-6-(trifluoromethyl)pyrimidine;Pyrimidine, 4-chloro-2-(1,1-dimethylethyl)-6-(trifluoromethyl)-
CAS No.193611-28-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDCTS517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCTS517 route product structure diagram
    ACDCTS517193611-28-8
Inquiry

2. ACDCTS517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLICS526 route compound structure diagram
    ACLICS5261044771-51-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCTS517 route product structure diagram
    ACDCTS517193611-28-8
Inquiry

Comments (0)